Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health ...

Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years.

BofA reinstated coverage of Pfizer (PFE) with a Neutral rating and $29 price target Uncertainty over COVID revenue streams plus a “tough” base ...

Pfizer (PFE) closed the latest trading day at $25.23, indicating a -1.33% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.82%. Meanwhile, the Dow ...

Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $25.73 which represents a slight increase of $0.03 or 0.12% from the prior close of $25.7. The stock opened at $25.74 and touched a low of ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, ...

Pharmaceutical giant Pfizer (PFE) now sports a dividend yield of 6.5%. Is this stock a smart addition to the income section ...

Wolfe Research has recently initiated Pfizer Inc (PFE) stock to Underperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on October 25, 2024, Citigroup had resumed the ...

Pfizer Inc (Symbol: PFE) has been named as a Top 25 ''Dividend ... BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and ...